Document is current
Any future updates will be listed below
-
Authors
Kato, Hirotaka
Tsukahara, Tomohide
Murata, Kenji
Nishikata, Hiromu
Mizue, Yuka
Sasaya, Takashi
Kubo, Terufumi
Kanaseki, Takayuki
Hirohashi, Yoshihiko
Oyagi, Atsushi
Maeda, Tatsuo
Miyazaki, Akihiro
Torigoe, Toshihiko
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20H03807)
Sapporo Clinical Laboratory Inc.
Japan Agency for Medical Research and Development (21cm0106309h0006)
AMED (24ama221328h0002)
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 11 February 2025
First Online: 4 March 2025
Declarations
:
: No potential conflict of interest was reported by the authors.
: This study was performed in accordance with the guidelines established by the Declaration of Helsinki and approved by the Ethics Committees of Sapporo Medical University (2–1-77).
: Blood from healthy donors was collected after obtaining informed consent from the donors for research purposes.
: T2-A24 cells were kindly provided by Dr. K. Kuzushima (Aichi Cancer Research Institute, Nagoya, Japan). All cell lines were authenticated by HLA-typing.
